FKD Therapies Oy
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer (NCT01687244) | FKD Therapies Oy | 2012-09-01 |
Track FKD Therapies Oy automatically
Every clearance here is in the API, with alerts when new ones post.